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The Effects of State Medicaid Expansions for Working-Age 
Adults on Senior Medicare Beneficiaries†
By Melissa McInerney, Jennifer M. Mellor, and Lindsay M. Sabik*
Do Medicaid expansions to working-age adults affect healthcare 
spending and utilization among older Medicare beneficiaries? 
Although economic theory provides conflicting predictions about the 
presence and direction of such spillover effects, it does identify cir-
cumstances when spillovers can reduce Medicare spending. Using 
data on Medicaid expansions during the 2000s and microdata from 
the Medicare Current Beneficiary Survey, we find that a 1 percentage 
point rise in the share of working-age adults eligible for Medicaid 
has modest effects on the average Medicare beneficiary’s spend-
ing, but reduces average spending by $477 among dual eligibles. 
Importantly, we find no evidence of adverse health effects. (JEL G22, 
H75, I12, I13, I18, I38, J14)
In the next decade, provisions in the Affordable Care Act (ACA) will expand public health insurance coverage to as many as 13 million persons per year 
(Congressional Budget Office 2014). Recent findings from the Oregon Health 
Insurance Experiment show that adults who are newly covered by Medicaid use 
more healthcare (Finkelstein et al. 2012, Taubman et al. 2014). Similarly, analy-
sis of Massachusetts’ comprehensive coverage expansion finds significant reduc-
tions in treatment delays and unmet healthcare needs (Long and Stockley 2011). 
In addition to these direct effects on the newly insured, persons already covered by 
health insurance could experience spillover effects from Medicaid expansions, such 
as reductions or delays in care (Boskin 2013). Given the needs of the aged and dis-
abled, spillovers that reduce access for Medicare beneficiaries may be particularly 
problematic if they also adversely affect health.
Economic theory, however, provides conflicting predictions about the pres-
ence and direction of spillovers from Medicaid expansions to Medicare healthcare 
* McInerney: Department of Economics, Tufts University, 8 Upper Campus Rd., Medford, MA 02155 (email: 
melissa.mcinerney@tufts.edu); Mellor: Department of Economics, College of William and Mary, P.O. Box 8795, 
Williamsburg, VA 23187 (email: jmmell@wm.edu); Sabik: Department of Health Policy and Management, 
University of Pittsburgh Graduate School of Public Health, 130 De Soto St., Pittsburgh, PA 15261 (email: lsabik@
pitt.edu). We are grateful for comments from session participants at the 2014 Biennial Conference of the American 
Society of Health Economists and the 2016 AcademyHealth Health Economics Interest Group, as well as semi-
nar participants at the University of North Dakota, the University of Virginia, Wellesley College, and the Boston 
College Center for Retirement Research. The authors gratefully acknowledge financial support from the Schroeder 
Center for Health Policy at the College of William and Mary and Tufts University, as well as research assistance 
from Michael Daly, Stephanie Hochhalter, and Bethany Welstead. This study was approved by the Protection of 
Human Subjects Committee at the College of William and Mary. The authors declare that they have no relevant or 
material financial interests that relate to the research described in this paper.
† Go to https://doi.org/10.1257/pol.20150402 to visit the article page for additional materials and author 
disclosure statement(s) or to comment in the online discussion forum.
VoL. 9 No. 3 409McINERNEY ET AL.: SPILLOVERS FROM MEDICAID TO MEDICARE
 provision. While no single theoretical model fits this exact type of spillover, insights 
can be drawn from models of physician behavior in two-payer settings or in the 
presence of heterogeneous payment arrangements. For example, in a mixed econ-
omy model of physician behavior, Medicaid expansions can increase the amount of 
healthcare supplied to the Medicare population, assuming that Medicaid expansions 
crowd out private insurance (e.g., Garthwaite 2012). Alternatively, in the absence 
of crowd out, the supply of healthcare to Medicare beneficiaries would not change 
since Medicaid reimburses at lower rates than Medicare. Elsewhere in the litera-
ture, theories about the spillover effects of restrictive insurance coverage (Glied 
and Zivin 2002) suggest a scenario where Medicaid expansions could decrease the 
healthcare supplied to Medicare beneficiaries. In addition to these competing the-
oretical predictions, the few existing empirical studies on this topic produce mixed 
results (Sommers, Baicker, and Epstein 2012; Bond and White 2013; Joynt et al. 
2013; Glied 2014; Joynt et al. 2015).
Our paper makes several key contributions to the small prior literature on spill-
overs from Medicaid expansions to Medicare beneficiaries. First, we review the 
extant theoretical literature to develop a set of testable predictions about spillover 
effects under different assumptions of crowd-out, physician interaction with both 
Medicaid and Medicare patients, and reimbursement rate differences between 
Medicaid and Medicare. This conceptual framework suggests that negative spillover 
effects (used here to refer to scenarios in which Medicaid expansions reduce the 
healthcare supplied to Medicare beneficiaries) can arise from physicians’ decisions 
to reduce the intensity of treatment offered to all patients in response to an increased 
number of patients covered by more restrictive insurance coverage, under the fixed-
cost hypothesis of Glied and Zivin (2002). Thus, we predict that negative spillovers 
will be more likely to occur for those Medicare patients seen by physicians who also 
treat large numbers of working-aged Medicaid patients, and residing in states where 
Medicaid reimburses at much lower rates than Medicare.
Second, we use microdata from the Medicare Current Beneficiary Survey (MCBS) 
Cost and Use files and state data from various sources to test the specific predictions 
regarding spillover effects. Since our conceptual framework suggests that spillover 
effects depend on the degree to which Medicare beneficiaries use the same healthcare 
providers as newly covered Medicaid recipients, we use discharge data to document 
that low-income Medicare enrollees who are covered by both Medicare and Medicaid 
(i.e., dual eligibles or duals) are more likely than other Medicare beneficiaries to be 
treated by physicians who also treat working-age Medicaid patients. We then test for 
spillover effects in separate samples of duals and non-duals in the MCBS.1 Our con-
ceptual framework also suggests that spillover effects will be larger when Medicaid 
payments are less generous, and we find some evidence that reductions in Medicare 
spending are larger in states with lower ratios of Medicaid to Medicare payments. 
To our knowledge, our study is the first to test for heterogeneous spillover effects.
Third, we use the MCBS data to examine the impact of Medicaid eligibility expan-
sions on health status as well as spending and utilization. This allows us to assess the 
1 We do not observe payer-mix for the providers who treat MCBS respondents. 
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welfare implications of observed spillovers. Further, we perform subgroup analyses 
to test whether Medicare beneficiaries who experience larger changes in spending 
also experience larger health effects.
Finally, we examine spillovers using a more comprehensive set of Medicaid 
expansions to working-age adults than previously considered. Most prior studies 
examine spillover effects in Massachusetts only (e.g., Bond and White 2013, Joynt 
et al. 2013, Joynt et al. 2015). The sole prior national study examines only large 
State Children’s Health Insurance Program (SCHIP, or currently CHIP) expan-
sions to adults (Glied 2014). In contrast, we identify the effects of public insur-
ance expansions across the entire United States using variation in eligibility arising 
from all state-level Medicaid and CHIP expansions to working-age adults during 
the 2000s. Thus, we are able to include other large expansions that the prior liter-
ature did not include, such as IowaCare, Insure Oklahoma, the New Mexico State 
Coverage Insurance program, and the Healthy Indiana Plan, all implemented under 
1115 waivers during the mid-2000s. Further, while most studies use a binary indica-
tor for an expansion, we use a measure of simulated eligibility, defined as the percent 
of a nationally representative sample of adults aged 20–64 that would be eligible for 
Medicaid based on the eligibility criteria in place in each state and year. Using this 
continuous measure allows the intensity of the expansions to vary across states.
To preview our results, we find that a 1 percentage point rise in the share of 
 working-age adults eligible for Medicaid reduces annual healthcare spending by 
$87 per Medicare beneficiary. However, consistent with the prediction that spill-
overs will be more significant among Medicare patients treated by physicians who 
also treat large numbers of Medicaid patients, we find larger reductions in annual 
healthcare spending of $477 per person among dual eligibles.
Importantly, we find little evidence that reductions in healthcare spending represent 
negative spillovers in a normative sense. That is, we do not find evidence that duals’ 
health, as measured by self-reported health status and mortality, worsens following 
a state Medicaid expansion. Thus, our overall results are consistent with declines 
in spending that reduce so-called “overuse” or “overtreatment” among Medicare 
enrollees. We also show that our results for spending cannot be explained by changes 
in the types of duals who take-up Medicaid coverage following expansions, by 
differential mortality among duals in expansion states, or by preexisting trends.
The leading explanation for our results is that they stem from physician responses 
to changes in fixed practice components brought on by changes in the heteroge-
neous payment environment. That is, when physicians who treat both Medicare 
and Medicaid patients experience increases in the share of Medicaid patients 
(whose coverage is more restrictive), these physicians reduce treatment intensity 
for all patients. This explanation is supported by some evidence that medical pro-
vider spending reductions are larger for duals residing in states with less generous 
Medicaid payments relative to Medicare.
I. Prior Literature on Medicaid Expansions
Numerous studies show that enrollment in public insurance increases individ-
uals’ healthcare use. For example, low-income adults covered by Oregon’s 2008 
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Medicaid expansion used more preventive care, outpatient care, and prescription 
drugs, and had a higher likelihood of having a hospitalization (Finkelstein et al. 
2014, Taubman et al. 2014). Relatedly, Wisconsin’s 2009 expansion of public insur-
ance to low-income childless adults increased outpatient and emergency depart-
ment visits among the newly insured, although it reduced inpatient hospitalizations 
(DeLeire et al. 2013).
Since our study looks at the impact of Medicaid eligibility expansions (as opposed 
to Medicaid participation), an important question is whether eligible individuals 
who live in states with expanded Medicaid eligibility use more healthcare. This may 
not always be the case if eligible individuals fail to take-up coverage or if expan-
sions crowd-out employer-sponsored or nongroup insurance coverage. Nonetheless, 
several findings suggest that state eligibility expansions do increase healthcare cov-
erage and utilization among eligible persons.
First, multiple studies show that state-level Medicaid expansions to parents 
lead to statistically significant increases in Medicaid participation and overall 
insurance coverage (e.g., Kronick and Gilmer 2002, Aizer and Grogger 2003, 
Busch and Duchovny 2005, Hamersma and Kim 2013, McMorrow et al. 2016). 
Second, estimates of crowd-out associated with adult Medicaid expansions 
are typically smaller than estimates associated with expansions to children 
(Buchmueller, Ham, and Shore-Sheppard 2015). This is not surprising because 
expansions to  working-age adults are usually more modest than CHIP expan-
sions to children; most expansions to these adults extend eligibility to persons 
at or below 200 percent of the federal poverty level (FPL), while 19 states cover 
children in families with incomes above 300 percent of the FPL through CHIP 
(KFF 2016). Thus, adults impacted by public insurance expansions are poorer 
than many children targeted by CHIP expansions, and these poorer adults are 
less likely to have private insurance in the first place. Accordingly, several studies 
find that parental Medicaid expansions have no statistically significant effects on 
private coverage for adults (e.g., Aizer and Grogger 2004, Busch and Duchovny 
2003, Hamersma and Kim 2013), and recent analysis by Atherly et al. (2016) 
shows that the majority of new adults covered by Medicaid HIFA waivers (which 
encourage new state approaches to expand insurance among childless adults) had 
no private insurance in the prior year. McMorrow et al. (2016) examines state 
Medicaid expansions to parents taking place between 1997 and 2009 and does 
find evidence of crowd-out, but those estimates are lower than estimates based on 
CHIP expansions to children. McMorrow et al. (2016) estimate that 33 percent 
of the increase in Medicaid coverage was due to a decline in employer sponsored 
private insurance, while Gruber and Simon (2008) estimate that 60 percent of the 
increase in children’s CHIP coverage was due to a drop in private coverage.
Third, several studies show that when states implement coverage expansions to 
working-age adults, their healthcare use increases. For example, Massachusetts’ 
2006 health reforms (which expanded coverage through a combination of Medicaid 
and subsidized private insurance) reduced reports of unmet healthcare needs due 
to cost and instances of delayed care, and increased the likelihood of having an 
office visit with a nurse practitioner or physician assistant (Long 2008; Long and 
Masi 2009; Long and Stockley 2011; Long, Stockley, and Dahlen 2012; Miller 
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2012; Long, Stockley, and Nordahl 2012).2 Sommers, Baicker, and Epstein (2012), 
which focuses on Medicaid expansions to childless adults in New York, Arizona, 
and Maine, find that the expansions led to significant increases in insurance cov-
erage and  self-reported health and significant reductions in delays in care. Further, 
 county-level mortality rates among 20–64-year-olds decreased in New York, relative 
to a comparison state that did not expand coverage.
In the prior literature that is directly related to our research question, there are a 
small number of studies that examine whether Medicaid expansions have spillover 
effects for the Medicare population.3 Several focus on spillovers from Massachusetts’ 
health reform to Medicare beneficiaries’ healthcare use. Joynt et al. (2015) examine 
chronically ill Medicare beneficiaries and find no change in outpatient service use 
and an increase in average spending following the 2006 Massachusetts reforms. 
In a related study, Joynt et al. (2013) find that the Massachusetts reforms reduced 
preventable hospitalizations for Massachusetts’ seniors, which they interpret as the 
absence of negative spillovers on Medicare beneficiaries. However, Bond and White 
(2013) find that although Medicare primary care use increased in Massachusetts 
overall, it decreased in the areas where the largest insurance expansions took place, 
evidence they interpret as negative spillovers. Sommers, Baicker, and Epstein 
(2012) find that seniors in three states with Medicaid expansions to childless adults 
experienced increased access to care as well as declines in cost-related care delays 
and mortality.4 Finally, in the only prior national study, Glied (2014) uses state-level 
data to examine how CHIP expansions to adults impacted Medicare hospitalization 
and Part B Medicare spending. She finds that in states with substantial CHIP expan-
sions, Medicare surgical discharge rates and Part B spending per beneficiary both 
fell by about 3 percent. To summarize, these prior studies provide mixed evidence 
for spillover effects and differ greatly in terms of their methods.
Our study differs from the bulk of the literature in our use of national data from 
all states and DC and a comprehensive measure of Medicaid eligibility expansions; 
because our eligibility measure is continuous, we can also account for differences in 
expansion size. Moreover, our work differs from all of the literature, including the 
national study by Glied (2014), in several important ways. First, we examine differ-
ent mechanisms behind spillover effects. For example, we use individual-level data 
to test for heterogeneous effects (by type of Medicare beneficiary and by Medicaid 
payment generosity) that are predicted by the economic theory underlying our anal-
ysis. Second, we use a more comprehensive set of spending, utilization, and health 
measures for individuals enrolled in Medicare, and third, we examine the persistence 
of spillover effects over time. Lastly, we also use our data to rule out explanations 
for our findings that are not related to spillovers, such as differential selection, dif-
ferential mortality, and preexisting trends.
2 In contrast, Long and Stockley (2011) find that the New York Medicaid expansion did not increase access to 
or use of healthcare, although it did increase insurance coverage. 
3 A few studies have looked at spillover effects from Medicaid parental coverage expansions to children’s 
healthcare use (e.g., Davidoff et al. 2003, Dubay and Kenney 2003). Garthwaite (2012) examines spillover effects 
from public insurance expansions to privately insured patients. 
4 Kolstad and Kowalski (2012) find related evidence that the Massachusetts expansion led to increases in 
 non-elderly Medicare inpatient discharges (table 5); however, they also report no change in elderly inpatient dis-
charges (table 2). 
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II. Conceptual Framework
We now turn to economic theories that explain the presence of spillovers across 
payers. While no single theoretical model fits the specific case of spillovers to 
Medicare beneficiaries arising from Medicaid expansions, important insights can be 
drawn from models of physician behavior in two-payer settings or in the presence 
of heterogeneous payment arrangements. In this section, we review both types of 
models and develop several testable implications for our empirical work.
A. Mixed-Economy Models
The most frequently cited model in the analysis of spillover effects is Sloan, 
Mitchell, and Cromwell (1978) or SMC, a mixed-economy model in which phy-
sicians treat patients covered by two payers. One payer is a government program 
that pays a fixed reimbursement per service; the other is a private insurer. Notably, 
the Glied (2014) study of spillovers to Medicare arising from CHIP expansions 
follows this general approach. Physicians are assumed to be price-takers for the 
public insurer (Medicare) and to face a downward-sloping demand for healthcare 
from adults under age 65. Glied (2014) then predicts that increased demand by 
adults under age 65 will reduce the quantity of care provided to Medicare patients. 
However, a key assumption is that the marginal revenue from a newly insured adult 
under age 65 exceeds the marginal revenue from a Medicare patient.5 This assump-
tion is reasonable for increases in employer-sponsored insurance that are also exam-
ined in Glied (2014), and perhaps even for CHIP expansions.6 However, in the 
context of the Medicaid expansions we focus on, this assumption is not supported; 
evidence clearly shows that Medicaid reimburses at lower levels than Medicare in 
almost all states (Zuckerman et al. 2003, Zuckerman and Goin 2012).
Another application of the SMC model examines physician responses to public 
insurance expansions specifically when the public insurer reimburses at a lower rate 
(e.g., Garthwaite 2012, Baker and Royalty 2000). Again, physicians are thought 
to face downward-sloping demand for private patients and to be price-takers for 
 publicly insured patients. This gives rise to the marginal revenue curve ABCD 
shown in Figure 1. A key assumption is that because of crowd out, the public 
insurance expansion decreases privately insured demand and the marginal revenue 
curve becomes EFCD.7 Physicians with no pre-expansion contact with  publicly 
insured patients, such as those with labor supply S′, will increase services provided 
to  publicly insured patients; physicians treating some publicly insured patients 
 pre-expansion, such as those with labor supply S″, will not change their share of 
patients covered by public insurance. However, in the absence of crowd-out, the 
expansion instead shifts the marginal revenue curve to ABGH;8 this affects only 
those physicians who,  pre-expansion, were constrained in treating publicly insured 
5 See figure 1 in Glied (2014). 
6 For example, Bronstein, Adams, and Florence (2004) report that CHIP reimbursement rates followed private 
insurer schedules in Alabama, a state with a standalone CHIP program. 
7 Private demand falls from AB to EF due to crowd out. 
8 Demand among publicly insured individuals rises from BC to BG. 
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patients by the  relatively low number of publicly insured patients (such as physi-
cians with labor supply S‴ ). Such physicians will increase services provided to 
publicly insured patients.
This version of the SMC model can be used to predict how Medicaid expansions 
affect the quantity of services supplied to Medicare patients. In our context, it is 
assumed that physicians face downward-sloping demand from patients covered by 
private insurance, are price-takers for patients covered by Medicare, and Medicaid 
reimburses at a lower rate than Medicare. The SMC model offers a prediction that 
varies with crowd out.
PREDICTION 1: If Medicaid coverage of working-age adults crowds out private 
insurance coverage, Medicaid expansions to working-age adults will increase the sup-
ply of services to Medicare patients. However, in the absence of crowd-out, Medicaid 
expansions would have no effect on the supply of services to Medicare patients.
As we noted earlier, several empirical studies of Medicaid expansions to 
 working-age adults produce much lower estimates of crowd-out than the CHIP 
expansions to children that Garthwaite (2012) uses this model to study. Absent 
crowd-out and reduced demand by the privately insured, the SMC model suggests 
there would be no change in Medicare services. Medicaid expansions simply create 
a new source of publicly insured patients whose care is reimbursed at rates typically 
below those of Medicare. Profit-maximizing physicians would have no incentive to 
treat a Medicaid patient over a Medicare patient, all else equal.
Quantity of medical services 
D
ol
la
rs
A 
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D 
E 
F 
G 
H 
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Figure 1. Physician Marginal Revenue and Labor Supply
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B. Alternate Models of Physician Behavior
Many studies show that Medicaid expansions to working-age adults increase 
healthcare utilization among this group (e.g., DeLeire et al. 2013, Long and Stockley 
2011). While this effect could be explained by the SMC model for physicians with 
supply curves similar to S‴ in Figure 1, Baker and Royalty (2000) support an alter-
native explanation.9 They posit that the profit-maximizing behavior modeled in 
SMC may not apply to “public” physicians who work outside of private office-based 
settings and instead work in hospitals, clinics, medical schools, universities, or state 
and local government. In such settings, institutional goals or government policies 
may lead physicians to provide care “to all patients who seek care, generally without 
regard to levels of Medicaid payment and private fees or to the type of insurance 
coverage by the patient” (Baker and Royalty 2000, 485). In this framework, public 
physicians meet the residual demand for care not supplied by private physicians. 
Unlike the SMC model, Baker and Royalty predict that Medicaid expansions will 
increase the amount of care supplied to those patients by public physicians even in 
the absence of crowd-out of private insurance. They offer empirical support for this 
by showing that expanded Medicaid eligibility increases patients’ access to physi-
cians working in public settings, but has no effect on access to private office-based 
physicians.10
While the SMC model does not offer insights into physician behavior for physi-
cians who treat patients regardless of payer (e.g., Medicaid, Medicare, uninsured, 
or private), a useful approach for considering spillovers in this context is Glied and 
Zivin (2002). The Glied and Zivin framework examines physician treatment inten-
sity when physicians treat some patients with fee-for-service insurance and oth-
ers in managed care plans, a context that is applicable to our analysis of Medicare 
and Medicaid patients. First, most Medicare enrollees are enrolled in traditional 
fee-for-service Medicare, and most low-income adults in Medicaid are in managed 
care plans. Specifically, in states that cover low-income adults under Medicaid 
expansions, the median managed care penetration rate in this population is 90 per-
cent (Kaiser Family Foundation 2015). Second and more importantly, even when 
Medicaid enrollees are in fee-for-service plans, the fact that Medicaid reimburses 
providers at lower rates than Medicare creates the type of payment environment 
heterogeneity that Glied and Zivin (2002) describe. We adopt their framework to 
consider physicians treating two sets of patients, one with more generous insurance 
coverage (fee-for-service or FFS in their context, Medicare in ours) and one with 
more restrictive insurance coverage (managed care in their context, Medicaid in 
ours).
The three models presented by Glied and Zivin (2002) offer different predic-
tions for Medicaid-Medicare spillovers in our context. In one model, physicians 
take patients with restrictive coverage only when they have excess capacity. In a sec-
ond model, physicians respond to increases in the share of patients with  restrictive 
9 Baker and Royalty (2000) also argue that it is unlikely that physicians, pre-expansion, are limited by the num-
ber of Medicaid patients seeking care. 
10 Our data do not permit us to identify physicians working in public settings. 
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coverage by inducing demand among patients covered by generous insurance. In a 
third model, Glied and Zivin (2002) allow there to be fixed and variable costs of 
production of physician services. Fixed costs are such items as durable equipment, 
office capacity, patient visit duration, weekly office hours, and whether/when to 
have call-in times available (He and White 2013); these costs are fixed in the sense 
that they do not vary by the type of insurance a patient has. Glied and Zivin theorize 
that physicians choose these fixed cost components based on the makeup of their 
practice. Therefore, if more patients with restrictive coverage enter a practice, the 
fixed cost components shift as if the patient base were entirely comprised of restric-
tive coverage. Glied and Zivin (2002) predict that treatment intensity of patients 
in generous plans will decrease as physicians treat more patients with restrictive 
coverage.
These models give rise to three additional predictions in our context:
PREDICTION 2: If physicians accept Medicaid patients because they have excess 
capacity, Medicaid expansions to working-age adults will have no effect on health-
care supplied to Medicare enrollees.
PREDICTION 3: If physicians respond to the less generous reimbursement of  newly 
insured Medicaid patients by inducing demand among patients with more generous 
coverage, Medicaid expansions will increase the supply of services to Medicare 
patients. Unlike Prediction 1, this result arises in the absence of crowd-out.
PREDICTION 4: As Medicaid expansions increase the share of Medicaid patients 
seen by the physician, the physician will alter fixed costs to reflect the level that 
would be optimal for a patient base of Medicaid patients, for whom reimbursement 
is lower. As a result, Medicaid expansions will reduce the healthcare supplied to 
Medicare patients.
The fixed cost hypothesis behind Prediction 4 is supported by empirical evi-
dence from several studies. Using patient-level data, Glied and Zivin (2002) find 
that increases in the practice’s HMO penetration rate decrease treatment intensity. 
A number of empirical studies on managed care spillover effects find similar pat-
terns. For example, Chernew, DeCicca, and Town (2008) and Baicker, Chernew, and 
Robbins (2013) find that exogenous changes in Medicare managed care penetration 
driven by changing Medicare Advantage payment rules reduce costs per hospital-
ization, length of hospital stay, and average healthcare spending for FFS Medicare 
beneficiaries. Changing practice pattern norms, similar to those hypothesized in 
Glied and Zivin (2002) are one proposed mechanism for this type of spillover, and 
studies that focus on the effects of managed care on the intensity of treatment for 
AMI patients support this (e.g., Bundorf et al. 2004).11
Finally, as extensions to Predictions 3 and 4, we posit that changes in Medicare 
treatment intensity will vary by the degree to which Medicare providers also treat 
11 See Chernew, Baicker, and Martin (2010) for a detailed review of the spillover literature. 
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patients covered by Medicaid as well as by the difference between Medicare and 
Medicaid payment rates, as stated below:
PREDICTION 5: Medicaid expansions to working-age adults will cause larger 
changes (increases or decreases) in the supply of services to Medicare patients who 
seek care from physicians also treating large shares of Medicaid patients.
PREDICTION 6: Medicaid expansions to working-age adults will cause larger 
changes (increases or decreases) in the supply of services to Medicare patients 
residing in states where Medicaid provider payments are much less generous than 
Medicare.
III. Data and Methods
To examine the spillover effects of Medicaid expansions to working-age adults 
on Medicare utilization, we use data from the Cost and Use files of the MCBS, a 
nationally representative sample of Medicare beneficiaries conducted by the Centers 
for Medicare and Medicaid Services (CMS). We use 9 years of data from 2001 
through 2009; in each year, approximately 10,000 Medicare beneficiaries are sur-
veyed as part of a rotating panel.12 We focus on Medicare beneficiaries age 65 and 
older enrolled in Medicare Parts A and B for the entire year and living in the com-
munity all year. Pooling observations from all years for which we have non-missing 
data on covariates in the models yields a sample of 71,709 individuals.13
The MCBS Cost and Use files are well-suited to our research question because 
they contain the most comprehensive account of the healthcare services received 
by Medicare beneficiaries as well as the amounts paid for these services and the 
sources of payment. CMS develops the Cost and Use files by combining and rec-
onciling survey responses from beneficiaries with Medicare administrative files. 
This reconciliation process improves upon the survey data by validating the accu-
racy of reported events, and it supplements Medicare payments from administra-
tive records with amounts paid by other payers reported on the survey. As a result 
the Cost and Use files report services received and amounts paid regardless of 
whether the payer was Medicare, patient out-of-pocket spending, private insurance, 
Medicaid, or some other source. This is especially important given that Medicare 
reimburses about half of the average beneficiary’s total healthcare costs (Lind 
2012).14 Additionally, the Cost and Use files report events and spending for events 
regardless of whether the respondent was in traditional fee-for-service Medicare or 
a Medicare Advantage plan.
12 The MCBS captures up to three years of healthcare utilization data for each respondent. 
13 There are 88,521 observations of persons aged 65 and older in the pooled MCBS Cost and Use files from 
2001 through 2009. We drop 9,860 observations of persons not enrolled in both Medicare Parts A and B for the 
full calendar year, another 5,826 observations of persons residing in a facility all or part of the year, and another 
1,126 observations lacking data on covariates. 
14 This statistic is not the same as the actuarial value of Medicare, which is 80 percent; the “about half ” statistic 
is calculated using healthcare spending that is not covered by Medicare (such as dental care, some home health care, 
and some institutional care). 
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A. Measures of Healthcare Spending, Utilization, and Health
We examine several measures of healthcare spending to capture changes in 
both the frequency and intensity of utilization. We use five measures of all-payer 
healthcare spending, including total healthcare spending on all service types, and 
healthcare spending for inpatient care, outpatient hospital care, medical provider 
events, and prescribed medicine.15 We then examine Medicare spending measures 
for the same five types of care, where spending includes both traditional Medicare 
and Medicare Advantage plan spending.16 The average MCBS respondent in our 
sample incurs nearly $11,400 per year in total healthcare spending. Approximately 
one-quarter is spent on inpatient care, and one-third is spending on medical provider 
events. The average respondent has close to $7,000 per year in Medicare spending. 
See Table 1 for additional descriptive statistics on the spending measures.
Our main analysis also includes other measures of healthcare utilization and 
three measures of self-reported health. We examine several measures of the quan-
tity of healthcare used, including the numbers of inpatient events, medical provider 
events, outpatient hospital events, and prescribed medicine events.17 See Table 3 
for additional descriptive statistics on the utilization measures. The three measures 
of self-reported health that we examine are an indicator of poor/fair general health, 
an indicator that health limits the respondent’s social activities, and an indicator 
that health is worse relative to last year. On average, one in five respondents is in 
poor or fair health, and one in five reports worsening health. About 12 percent of 
respondents report that health limits their social activities. See Table 5 for additional 
summary statistics on self-reported health status.
B. Measure of Medicaid Expansions to Working-Age Adults
We measure Medicaid expansions to working-age adults with a state-level mea-
sure of the percent of the population aged 20–64 eligible for Medicaid in each year. 
Since a well-known problem in studies identifying the effects of coverage expan-
sions is that actual program enrollment reflects local economic conditions as well as 
policy variables, we follow the practice of quantifying simulated eligibility, or the 
percent of a nationally representative sample of persons who would be eligible using 
the eligibility rules in place for each state and year (e.g., Currie and Gruber 1996, 
Gruber and Simon 2008).
We use information on Medicaid income eligibility rules for non-elderly, non-
disabled adults from various sources. Reports from the Kaiser Family Foundation 
provide the main source of information on parental coverage for most years (Kaiser 
Family Foundation State Health Facts 2014). We supplement this information with 
other reports, fact sheets, and administrative documents from foundations, states, 
and the Centers for Medicare and Medicaid Services. Certain gaps in information 
15 These measures are drawn from the Person Summary RIC. Medical provider events include various medical 
services, such as care provided by physicians and others under the supervision of physicians, including separately 
billing doctors and separately billing labs, and other medical expenses. 
16 These measures are drawn from the Service Summary RIC. 
17 These measures are defined from Person Summary RIC measures and pertain to all payers. 
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were addressed through conversations with state officials. The compiled data sum-
marize Medicaid income eligibility thresholds as a percent of the FPL for parents 
and childless adults in each state-year through multiple pathways, including tra-
ditional 1931 parental coverage and 1115 waiver coverage (including through the 
HIFA waiver program). For the simulated eligibility measure used here, we include 
eligibility through all Medicaid pathways that provide comprehensive coverage 
(excluding a small number of waiver programs that primarily provide premium sup-
port for  employer-sponsored health insurance).
We construct the simulated eligibility measure using all non-elderly adults (age 
20–64 years) in the 2000 CPS March Supplement. For each individual, we calcu-
late income as a percent of FPL based on family size. We then determine eligibility 
for Medicaid for this consistent sample in each state and year based on a compar-
ison of parental status, employment status, and income to the compiled eligibility 
information from the states. We then aggregate the data, using the appropriate sur-
vey weights, to construct a state-year measure of simulated eligibility, defined as 
the percentage of the national non-elderly adult sample that would be eligible for 
Medicaid in each state and year.18
The simulated eligibility measure has a mean of 4.99 percent (weighting the 
data by observations in the MCBS) and ranges from 0.7 percent (in Alabama and 
Arkansas) to 48 percent (in Hawaii). Mean simulated eligibility increases over our 
sample period from 3.08 percent to 6.74 percent as a consequence of numerous 
state public insurance expansions to childless adults and parents. Our identifying 
variation arises from Medicaid expansions occurring in different states over time. 
For example, simulated eligibility increased by 24 percentage points in Indiana fol-
lowing the implementation of the 2008 Healthy Indiana Plan, a plan that extended 
Medicaid coverage to adults with household incomes up to 200 percent of the fed-
eral poverty level. We document 13 instances of simulated eligibility increasing by 
more than 5 percentage points in consecutive years, and the mean increase in simu-
lated eligibility corresponding to these expansions is 12.6 percentage points.19
C. Testing for Spillovers
We first test Predictions 1 through 4 by estimating models of spending and health-
care use. We estimate models of healthcare spending using two-part models,20 an 
approach commonly used in the healthcare literature to model both the likelihood 
of receiving healthcare and the amount of healthcare received, which is appropriate 
for outcomes with a large number of zeros (Deb and Trivedi 2012).21 The two parts 
18 California implemented a large Medicaid expansion in a subset of counties in 2007. We calculate separate 
measures of simulated eligibility for expansion and non-expansion counties and calculate a population weighted 
average of these measures to represent overall simulated eligibility for the state of California. 
19 Most year-to-year changes are small: the average change in simulated eligibility year-to-year is less than 
1 percentage point. This reflects updates to income eligibility thresholds for parental coverage. 
20 Two-part models are estimated using the -tpm- command in Stata (Belotti and Deb 2012). Marginal effects 
for our key explanatory variable are estimated with the -margins- command in Stata. 
21 It is common to have a large number of zeros in distributions of healthcare spending. For example, in our 
sample of Medicare beneficiaries, only 19 percent have any inpatient spending. 
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of the model are estimated independently. For the first part, we estimate the probit 
model below:
(1)  P(  y ist > 0 | SimEli g s,t−1 ,  X ist ) = Φ(  β 1 SimEli g s,t−1 + Γ X ist ) ,
where y is a measure of spending. For the second part, we estimate a generalized 
linear model (GLM), as shown below:
(2)  ln  (E (  y ist | SimEli g s,t−1 ,  X ist ,  y ist > 0) ) =  α 1 SimEli g s,t−1 + Π X ist .
We choose a log-link function (to account for the skewed nature of our spending 
data) and we assume a Poisson function for the variance (i.e., variance is propor-
tional to the mean) (Manning and Mullahy 2001).22 Then the predicted change in 
spending is given by the product of the probability of having any spending from the 
first part (probit) and the expected spending levels from the second part (GLM):
(3)  E(  y ist | SimEli g s,t−1 ,  X ist ) 
   = P (  y ist > 0 | SimEli g s,t−1 ,  X ist ) × E (  y ist | SimEli g s,t−1 ,  X ist ,  y ist > 0) .
We estimate models of the numbers of inpatient, medical provider, outpatient, or 
prescribed medicine events using Poisson models since the dependent variables are 
counts, or non-negative integers.
In all models, the key explanatory variable is the percentage of a nationally repre-
sentative sample of adults aged 20–64 that would be eligible for Medicaid coverage 
following each state’s eligibility rules in the prior year (denoted SimElig (t − 1) in 
the tables). We focus on the prior year’s eligibility rules since many changes in pro-
gram eligibility take place mid-year and our simulated eligibility variable is based 
on the program rules in place for most (but not necessarily all) of a calendar year. 
Thus, SimElig (t − 1) consistently captures a full calendar year over which eligi-
bility changes are in place after an expansion. Further, changes in enrollment and 
utilization among the working-age Medicaid population will not occur immediately 
after an eligibility change, but will phase in over a number of months. Estimates of 
a positive relationship between simulated eligibility and spending would be con-
sistent with both profit-maximizing physicians and crowd-out of private insurance 
(Prediction 1) and demand inducement (Prediction 3). The absence of a relation-
ship between simulated eligibility and spending would support profit-maximization 
in the absence of crowd-out (Prediction 1) or excess capacity among physicians 
(Prediction 2). Finally, a negative relationship would be consistent with physicians 
changing their patterns of practice as more of their patients are covered by a restric-
tive insurer (Prediction 4).
22 The log-link function is of course equivalent to
 E(  y ist | SimEli g s,t−1 ,  X ist ,  y ist > 0) =  e ( α 1 SimEli g s,t−1 +Π X ist ) . 
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We include controls for various determinants of spending and utilization. 
Individual-level controls defined from the MCBS include age and its square, sex, 
race/ethnicity, household income and its square, household size, educational attain-
ment, marital status, veteran status, and residence in an urban area. We also include 
controls for the number of chronic conditions, smoking, and body mass index. See 
online Appendix Table A1 for additional descriptive statistics for the various sam-
ples. State-level controls include the annual unemployment rate and the annual 
percent of Medicaid enrollees in comprehensive managed care plans.23 Models of 
total healthcare spending include area-level controls for the hospital wage index 
and three physician practice costs indices. In models of inpatient and outpatient 
hospital spending, we control for the hospital wage index, and in models of medical 
provider spending we control for the physician practice cost indices.24 All models 
include state and year fixed effects and a full set of state-specific linear time trends 
to account for unobservable factors within the state that impact healthcare spending 
and utilization and vary over time. We adjust the standard errors of the estimated 
regression coefficients for clustering at the state-level. For the two-part models, we 
report marginal effects and delta method standard errors.
Prediction 5 suggests that the largest changes in spending and utilization will 
occur among those Medicare beneficiaries whose physicians treat large shares of 
working-age Medicaid patients.25 We test this prediction by estimating our models 
for separate samples of dual-eligible and non-dual Medicare enrollees. Dual-eligible 
enrollees are low-income seniors who are eligible for Medicare because of their 
age and eligible for Medicaid because of their low incomes. Since Medicaid is the 
payer of last resort, physicians who treat duals are reimbursed by Medicare, while 
Medicaid covers cost sharing for the patient. Since both working-aged and elderly 
Medicaid enrollees are low income, we expect that dual eligibles are more likely 
than non-duals to reside in the same communities and to seek care from the same 
physicians as working-age Medicaid recipients. To illustrate the ties these patients 
share, we use Healthcare Cost and Utilization Project (HCUP) data and show that 
physicians treating dual-eligible beneficiaries are roughly twice as likely to treat 
working-age Medicaid patients than physicians treating non-duals.26 The results are 
shown in online Appendix Table A2. This pattern holds for both ambulatory care 
23 CMS enrollments reports from recent years are available online (http://www.medicaid.gov/medicaid-chip-
program-information/by-topics/data-and-systems/medicaid-managed-care/medicaid-managed-care-enrollment-
report.html) and data were obtained directly from CMS staff. 
24 We obtained wage index data for 2000–2008 from the NBER website (www.nber.org/data/CBSA-MSA-
wage-index.html) and for 2009 from the CMS website (www.cms.gov/Medicare/Medicare-Fee-for-Service-
Payment/AcuteInpatientPPS/Wage-Index-Files-Item). We obtained data on physician practice cost indices from 
the CMS website (https://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx). All data were 
merged to MCBS respondents by their county of residence, using crosswalks from MSA/CBSA/carrier locality to 
county as appropriate. 
25 Note that the potential for Medicare patients in general to be treated by physicians also treating Medicaid 
patients is fairly significant. Using data from the 2000 –2001 Community Tracking Study—Physician Survey, we 
calculate that over 71 percent of physicians report that their practice accepts some patients covered by Medicare and 
at least some patients covered by Medicaid. Moreover, 42 percent of physicians report that their practice accepts all 
new Medicare and all new Medicaid patients. 
26 We use one year of the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID) and 
State Ambulatory Surgery and Services Databases (SASD) from the three states that report multiple payer fields and 
a physician identification number on each discharge record (Kentucky, Maryland, and New Jersey). In each state, 
we examine a sample of physicians identified as the attending physician for patients 18 years and up and for at least 
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as well as inpatient care, even though inpatient care is likely less common among 
working-age adults. Thus, Prediction 5 would be supported by evidence that the 
effects of Medicaid expansions on spending and utilization are larger among dual 
eligibles.
Prediction 6 suggests that negative spillovers will be larger in states where 
Medicaid is relatively less generous compared to Medicare. To test this, we measure 
payment generosity with the Medicaid-to-Medicare physician fee ratio for primary 
care, as reported in Zuckerman et al. (2003). This ratio is constructed for each state 
by first taking  the ratio of the Medicaid fee to the Medicare fee for each service 
and then using spending weights to combine the service-specific ratios into a single 
Medicaid-to-Medicare ratio (MMR). We use data from 2003, which is the earliest 
year for which this measure is available for all states. We then separately estimate 
spending models for duals residing in states with a relatively low MMR and duals 
residing in states with a higher MMR. We define “low” MMR values as those below 
the twenty-fifth, fiftieth, or seventy-fifth percentile of Medicaid generosity. A find-
ing that spending changes are larger among respondents living in low MMR states 
would be consistent with Prediction 6.
IV. Results
A. Spillover Effects on Spending and Utilization
Table 1 reports the key results from two-part models of healthcare spending, 
namely, the estimated marginal effects of a 1 percentage point increase in the per-
cent of working-age adults eligible for Medicaid. Results from the models estimated 
with the full sample of Medicare beneficiaries are shown in column 1. The all-payer 
spending models shown in the top panel suggest that Medicaid expansions have very 
modest effects on Medicare beneficiaries’ total spending. Namely, a 1 percentage 
point rise in the percent of adults eligible for Medicaid (a 20 percent increase) reduces 
overall spending by $87 per beneficiary (a 0.7 percent decrease). The decrease 
reflects small declines in spending on medical providers ($53 per beneficiary), out-
patient hospital care ($22), and prescribed medicines ($9). In the Medicare spend-
ing models shown in the bottom panel, the marginal effects of simulated eligibility 
increases are smaller still, and statistically significantly different from zero in only 
one case. In that case, a 1 percentage point increase in the share of adults eligible for 
Medicaid corresponds to a $9 decline in Medicare spending for outpatient hospital 
care. Overall, results from the full sample suggest that Medicaid expansions cause 
either small decreases in Medicare spending (consistent with Prediction 4, the fixed 
costs hypothesis) or no change in Medicare spending (consistent with Predictions 1 
and 2). We see no support for Prediction 3, that Medicaid expansions will increase 
supply to Medicare beneficiaries through increased demand inducement.
The remaining columns of Table 1 report marginal effects from two-part mod-
els estimated separately for dual eligibles and all other Medicaid beneficiaries 
one Medicare patient. We then calculate the fraction of those physicians who are also identified as the attending 
physician on the discharge records of 18–64-year-old patients with Medicaid coverage. 
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Table 1—Effects of Eligibility Expansions on Healthcare Spending by Type of Insurance
Marginal effect of SimElig (t − 1)
Full sample Dual eligibles Non-duals
(1) (2) (3)
Panel A. All payer spending, 2009$
All payments, all service types −86.858 −476.602 −38.664
(34.23) (82.82) (40.55)
 
_
 y = 11,372  _ y = 14,652  _ y = 10,978
(19,131) (22,284) (18,677)
All payments for inpatient events 7.274 −229.681 32.608
(14.22) (57.94) (12.38)
 
_
 y = 2,992  _ y = 4,361  _ y = 2,828
(9,868) (13,128) (9,388)
All payments for medical −52.981 −94.239 −47.316
 provider events (25.37) (35.57) (29.54)
 
_
 y = 3,642  _ y = 3,913  _ y = 3,610
(8,036) (6,276) (8,225)
All payments for outpatient −21.591 −52.098 −18.060
 hospital events (7.98) (12.93) (8.54)
 
_
 y = 1,278  _ y = 1,484  _ y = 1,253
(5,013) (4,744) (5,044)
All payments for prescribed −9.058 −2.170 −8.972
 medicine events (2.71) (9.80) (3.23)
 
_
 y = 2,239  _ y = 3,135  _ y = 2,131
(2,578) (3,357) (2,448)
Panel B. Medicare spending, 2009$
Medicare payments, −29.321 −432.937 21.235
 all service types (23.82) (75.80) (19.63)
 
_
 y = 6,969  _ y = 11,055  _ y = 6,489
(14,297) (19,557) (13,480)
Medicare payments for 4.198 −214.431 26.827
 inpatient events (11.86) (52.79) (10.63)
 
_
 y = 2,619  _ y = 3,946  _ y = 2,460
(9,052) (12,179) (8,587)
Medicare payments for medical −7.411 −79.890 1.280
 provider events (5.70) (20.61) (4.88)
 
_
 y = 2,252  _ y = 2,739  _ y = 2,193
(4,182) (4,399) (4,151)
Medicare payments for −9.331 −42.393 −5.251
 outpatient hospital events (4.05) (12.07) (4.12)
 
_
 y = 821  _ y = 1,161  _ y = 780
(2,943) (3,914) (2,801)
Medicare payments for −1.885 8.707 −1.753
 prescribed medicine events (3.29) (11.18) (2.74)
 
_
 y = 545  _ y = 1,606  _ y = 418
(1,650) (3,042) (1,337)
Notes: Sample sizes range from 71,429 to 71,699 for the full sample; 7,461 to 7,679 observations for dual eligi-
bles; and 63,650 to 64,019 observations for non-duals. All models include controls for age and age squared, high-
est level of educational attainment, sex, race or ethnicity, veteran status, marital status, urban residence, household 
income and its square, smoking participation, BMI, number of chronic conditions, the percent of state Medicaid 
enrollees in comprehensive MCO plans, and the state unemployment rate. All models also include year and state 
fixed effects and a full set of state-specific linear time trends. Controls for the hospital wage index and three physi-
cian practice costs indices are added to models of all service spending; the hospital wage index is added to models 
of inpatient and outpatient hospital spending, and physician practice cost indices are added to models of medical 
provider spending. Robust standard errors clustered by state are reported in parentheses below estimated marginal 
effects. The mean (standard deviation) of the outcome variable for the regression sample is reported for each model.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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(non-duals). Based on Prediction 5 and the analysis of discharge data reported ear-
lier, we expect Medicaid expansions to working-age adults will have larger (positive 
or negative) effects on healthcare spending among dual eligibles. The results in 
column  2 show that duals experience large reductions in healthcare spending as 
Medicaid coverage to working-age adults expands. A 1 percentage point increase 
in the Medicaid eligibility of working-age adults reduces duals’ all-payer spending 
by $477 and reduces their Medicare spending by $433. The overall reduction comes 
from reductions in inpatient spending ($214–$230), medical provider spending 
($80–$94), and hospital outpatient spending ($42–$52). For the non-duals, changes 
in simulated eligibility have no effect on total Medicare and all-payer spending. 
There are some significant marginal effects when we measure spending by type of 
setting; for example, increases in Medicaid eligibility have small positive effects on 
inpatient spending and small negative effects on all-payer hospital outpatient spend-
ing. Overall, the results in Table 1 support Predictions 4 and 5—that negative spill-
overs exist for beneficiaries treated by physicians who also treat more working-age 
Medicaid patients.27
Table 2 examines the two-part models more closely to see whether the negative 
spillovers we document for dual eligibles arise from reductions in the likelihood 
of receiving any care and/or reductions in the intensity of care (e.g., spending per 
encounter). For the most part, the marginal effects of Medicaid eligibility expansions 
are working through reductions in healthcare on the intensive margin (as  evident 
in the size and significance of the GLM marginal effects reported in  column 2). 
Medicaid expansions usually do not have negative significant effects in the probit 
models of any spending, except for inpatient spending. For example, in the probit 
model of any all-payer inpatient spending, the marginal effect of a 1 percentage 
point increase in Medicaid eligibility is −0.004. Since 25.2 percent of the dual eligi-
ble population has any inpatient spending, this corresponds to a 1.6 percent decline 
in the probability of any inpatient use. The evidence in Table 2 provides further sup-
port for the fixed cost hypothesis behind negative spillover effects, which suggests 
that physicians who experience an increase in patients with more restrictive cover-
age will reduce treatment intensity, or treatment on the intensive margin.
In Table 3, we examine the effects of Medicaid expansions on measures of health-
care utilization among Medicare beneficiaries. We present results from Poisson 
models of the counts of inpatient events, outpatient hospital visits, medical pro-
vider events, and prescribed medical events. For the average Medicare beneficiary, 
increased Medicaid eligibility has no effect on inpatient events and causes a small 
 significant decline in the number of medical provider events. For non-duals, increased 
Medicaid eligibility has no effect on any measure of healthcare utilization. In con-
trast, Medicaid expansions have large negative effects on dual-eligible beneficia-
ries’ inpatient admissions and medical provider events. Specifically, a 1 percentage 
27 Other dimensions of heterogeneity between duals and non-duals could contribute to the results we observe. 
For example, we considered whether the spending differences between duals and non-duals are driven by the greater 
illness burden among duals and examined differences in spending effects between healthy and sick non-duals. We 
did not see a pattern of larger negative spending reductions among unhealthy non-duals, suggesting that the dif-
ferences we observe between duals and non-duals are not driven by their greater illness burden (results available 
upon request). Nonetheless, other differences, such as differences in residential location, may still play some role. 
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point increase in Medicaid eligibility reduces the number of inpatient admissions 
by 5.6 percent and the number of medical provider events by 3.1 percent among 
dual eligibles. These empirical results are again consistent with negative spillovers 
explained by changes in fixed practice costs, and consistent with Predictions 4 and 5.
We next examine support for Prediction 6, which suggests that negative spill-
overs will be larger in states where Medicaid is relatively less generous compared 
to Medicare. Results from this exercise are shown in Table 4, which reports the 
combined marginal effects from two-part models. Under Prediction 6, we would 
expect to see that Medicaid expansions cause larger spending reductions for 
individuals residing in less generous states (i.e., with low ratios of Medicaid to 
Medicare fees for primary care). We focus on the results presented in column 3 for 
medical provider spending because the measure of payment generosity pertains 
to relative physician fees for primary care. We note that in every case, there is a 
statistically significant reduction in spending for medical provider events in the 
Table 2—Effects of Eligibility Expansions on Healthcare Spending, 2001–2009, Dual Eligibles
Coefficient on SimElig (t − 1)
Marginal effect of 
SimElig (t − 1) ObservationsProbit  (marginal effect)
GLM  
(marginal effect)
(1) (2) (3) (4)
Panel A. All payer spending, 2009$
All payments, all service types 0.001 −496.409 −476.602 7,525
(0.001) (84.227) (82.825)
All payments for inpatient −0.004 −620.501 −229.681 7,679
 events (0.002) (197.772) (57.944)
All payments for medical 0.002 −102.769 −94.239 7,461
 provider events (0.001) (36.809) (35.572)
All payments for outpatient −0.0004 −68.856 −52.098 7,679
 hospital events (0.002) (16.499) (12.929)
All payments for prescribed 0.001 −4.254 −2.170 7,507
 medicine events (0.001) (10.146) (9.802)
Panel B. Medicare spending, 2009$
Medicare payments, all service 0.00001 −447.849 −432.937 7,466
 types (0.001) (77.958) (75.799)
Medicare payments for −0.004 −592.013 −214.431 7,679
 inpatient events (0.002) (180.688) (52.788)
Medicare payments for medical −0.0003 −84.936 −79.890 7,660
 provider events (0.0014) (21.836) (20.607)
Medicare payments for −0.002 −56.068 −42.393 7,679
 outpatient hospital events (0.003) (15.539) (12.068)
Medicare payments for 0.001 12.234 8.707 7,672
 prescribed medicine events (0.001) (23.476) (11.179)
Notes: All models control for age and age squared, highest level of educational attainment, sex, race or ethnicity, 
veteran status, marital status, urban residence, household income and its square, enrollment in FFS Medicare, smok-
ing participation, BMI, the number of chronic conditions, the percent of state Medicaid enrollees in comprehensive 
MCO plans, and the state unemployment rate. All models also include year and state fixed effects and a full set of 
state-specific linear time trends. Controls for the hospital wage index and three physician practice costs indices are 
added to models of all service spending; the hospital wage index is added to models of inpatient and outpatient hos-
pital spending and physician practice cost indices are added to models of medical provider spending. Robust stan-
dard errors clustered by state are reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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less generous states and no statistically significant change in spending for medi-
cal provider events in the more generous states. Further, the differential spending 
reductions become smaller in magnitude as we examine results for cutoffs going up 
the distribution of state generosity (i.e., as the “less generous states” include states 
with higher MMRs). Together, these patterns in the results for medical spending 
events provide some evidence in support of Prediction 6—that negative spillovers 
will be larger in states where Medicaid reimburses at a less generous level relative 
to Medicare.
B. Effects on Health
We next turn to the question of whether Medicaid expansions to working-age 
adults impact the health of seniors in Medicare. Given the pattern of results thus 
far, we should be most concerned about potential adverse effects on duals. We pres-
ent results from linear probability models for several measures of poor health in 
Table 3—Effects of Eligibility Expansions of Healthcare Utilization by Type of 
Insurance
Poisson coefficient on SimElig (t − 1) 
Full sample Dual eligibles Non-duals 
(1) (2) (3)
Number of inpatient events −0.005 −0.056 0.005
(0.005) (0.008) (0.004)
 
_
 y = 0.31  _ y = 0.47  _ y = 0.29 
(0.82) (1.08) (0.78)
N = 71,695 N = 7,679 N = 64,015
Number of medical provider −0.004 −0.031 −0.0005
 events (0.002) (0.007) (0.002)
 
_
 y = 26.06  _ y = 30.89  _ y = 25.48
(30.28) (36.96) (29.33)
N = 71,707 N = 7,679 N = 64,027
Number of outpatient hospital −0.004 −0.013 −0.002
 events (0.003) (0.010) (0.003)
 
_
 y = 4.43  _ y = 5.62  _ y = 4.29 
(8.80) (11.50) (8.40)
N = 71,707 N = 7,679 N = 64,027
Number of prescribed medicine −0.002 −0.002 −0.001
 events (0.001) (0.003) (0.001)
 
_
 y = 33.68  _ y = 54.49  _ y = 31.18 
(31.95) (46.74) (28.69)
N = 71,707 N = 7,679 N = 64,027
Notes: All models include controls for age and age squared, highest level of educational attain-
ment, sex, race or ethnicity, veteran status, marital status, urban residence, household income 
and its square, smoking participation, BMI, number of chronic conditions, the percent of state 
Medicaid enrollees in comprehensive MCO plans, and the state unemployment rate. All mod-
els also include year and state fixed effects and a full set of state-specific linear time trends. 
Robust standard errors clustered by state are reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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Table 5, and find no evidence of adverse health effects. In the full sample, increases 
in simulated Medicaid eligibility are associated with a significant decrease in the 
likelihood that the respondent says health limits his/her social activities.28 Even 
among the dual eligible enrollees whose healthcare use is reduced by eligibility 
expansions, the coefficients of simulated Medicaid eligibility changes are never sta-
tistically significant.
We further investigate the potential for adverse health effects with additional 
measures from the MCBS—mortality, preventive care use, and potentially avoid-
able hospitalizations. For this additional analysis, we focus on the dual eligibles 
since their healthcare spending and utilization is most affected by Medicaid expan-
sions.29 We first look at one-year mortality, which can be defined for some Medicare 
beneficiaries in each survey year using the rotating panel design of the survey. 
28 It is possible that part of the health improvements observed in this model could be due to increases in insur-
ance coverage that occur when Medicaid expansions increase Medicaid participation by adults prior to their 
Medicare enrollment. 
29 For completeness, we also estimated the mortality, preventive care, and avoidable hospitalization models 
for non-duals (although since an avoidable hospitalization is a claims-based measure, it can be defined only for 
non-duals in FFS Medicare). The results are available upon request. We find little evidence that Medicaid eligibility 
expansions have adverse effects on these alternate measures of health among non-duals. 
Table 4—Effects of Eligibility Expansions on Duals’ Healthcare Spending by Medicaid Payment 
Generosity
All payer healthcare spending measures, 2009$  
(Marginal effect of SimElig(t − 1))
Total 
payments
Inpatient 
events
Medical 
provider events
Outpatient 
hospital events
Prescribed 
medicine events
(1) (2) (3) (4) (5)
States with generosity below −422.9 −187.3 −190.8 −96.0 41.3
 twenty-fifth percentile (268.4) (134.8) (65.0) (29.3) (23.3)
States with generosity at or −392.9 −277.7 −28.1 −28.0 −8.3
 above twenty-fifth percentile (134.5) (75.1) (41.0) (17.5) (9.5)
States with generosity below −659.8 −328.7 −117.8 −67.2 −25.6
 fiftieth percentile (122.3) (95.4) (56.6) (26.8) (10.3)
States with generosity at or −256.8 −265.4 17.3 −43.8 −5.7
 above fiftieth percentile (212.2) (101.1) (63.9) (19.2) (17.3)
States with generosity below −491.6 −224.0 −79.4 −45.1 −15.1
 seventy-fifth percentile (173.8) (115.3) (44.9) (25.4) (11.2)
States with generosity at or −469.4 −344.4 −15.3 −36.3 −0.94
 above seventy-fifth percentile (180.7) (114.3) (77.3) (28.8) (22.2)
Notes: Sample sizes range from 966 to 6,146. State generosity is measured by the distribution of the Medicaid/
Medicare fee ratio for primary care in the year 2003 (Zuckerman et al. 2003). All models include controls for age 
and age squared, highest level of educational attainment, sex, race or ethnicity, veteran status, marital status, urban 
residence, household income and its square, smoking participation, BMI, number of chronic conditions, the per-
cent of state Medicaid enrollees in comprehensive MCO plans, and the state unemployment rate. All models also 
include year and state fixed effects and a full set of state-specific linear time trends. Controls for the hospital wage 
index and three physician practice costs indices are added to models of all service spending; the hospital wage index 
is added to models of inpatient and outpatient hospital spending and physician practice cost indices are added to 
models of medical provider spending. Robust standard errors clustered by state are reported in parentheses below 
estimated marginal effects.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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Table 6 column 1 presents the results of a linear probability model of mortality for 
the roughly 4,400 dual eligibles (57 percent) for whom we are able to measure it.30 
About 7.2 percent of these duals die in the year after the survey year (compared to 
4.5 percent of the full sample respondents for whom we can observe mortality). 
We find no evidence that increases in Medicaid eligibility to working-age adults 
increase mortality among duals. In columns 3 and 5, we include additional lags of 
the simulated eligibility variable to assess longer term effects of eligibility changes 
on health. We discuss these results in more detail below; overall we do not find 
strong evidence of mortality effects in any of the models.
We next look more closely at specific types of healthcare that may be linked to 
health in ways not reflected by self-reported health assessments. Online Appendix 
Table A3 reports models of whether duals receive preventive healthcare, such as 
cancer screenings, blood pressure tests, and flu shots. These indicators are defined 
from self-reported responses to questions on the survey portion of the MCBS. The 
results provide no evidence that Medicaid expansions alter dual eligibles’ utilization 
of preventive care.
30 We examine mortality in year t + 1, two years following expansions that occur in year t − 1. We only observe 
mortality for individuals who are not rotating out of the MCBS. 
Table 5—Effects of Eligibility Expansions on Self-Reported Health Status by 
Type of Insurance
OLS coefficient of SimElig (t − 1)
Full sample Dual eligibles Non-duals
(1) (2) (3)
General health is fair or poor −0.0001 −0.0005 −0.00005
(0.0005) (0.0014) (0.0006)
 
_
 y = 0.209  _ y = 0.405  _ y = 0.185
N = 71,435 N = 7,640 N = 63,795
Health limits social activities −0.0007 −0.0020 −0.0005
(0.0004) (0.0023) (0.0005)
 
_
 y = 0.123  _ y = 0.238  _ y = 0.109
N = 71,553 N = 7,646 N = 63,907
Health is worse compared to one year ago −0.0001 0.0010 −0.0002
(0.0006) (0.0024) (0.0007)
 
_
 y = 0.214  _ y = 0.305  _ y = 0.204
N = 71,581 N = 7,661 N = 63,920
Notes: All models include controls for age and age squared, highest level of educational attain-
ment, sex, race or ethnicity, veteran status, marital status, urban residence, household income 
and its square, smoking participation, BMI, the percent of state Medicaid enrollees in compre-
hensive MCO plans, and the state unemployment rate. All models also include year and state 
fixed effects and a full set of state-specific linear time trends. Robust standard errors clustered 
by state are reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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Finally, we look at potentially avoidable hospitalizations.31 These include hos-
pitalizations for dehydration, hypertension, or diabetes complications, among other 
conditions, which if appropriately treated in an outpatient setting are unlikely to 
require an inpatient admission. We use claims data to define an indicator for any pre-
ventable hospitalization and indicators for five specific types of hospitalizations that 
we can model for beneficiaries at risk for that condition. For example, we examine 
hospitalizations for diabetes-related complications among respondents with a prior 
diabetes diagnosis. Since claims data are required to identify these hospitalizations, 
these models are estimated only for dual eligibles in FFS plans. Online Appendix 
Table A4 reports the results. Overall, there is no evidence that increases in Medicaid 
eligibility increase the likelihood that a dual eligible has an avoidable hospitaliza-
tion. In contrast, we find that increases in Medicaid eligibility have a significant 
negative effect on hospitalizations for COPD or asthma, as well as marginally signif-
icant negative effects on hospitalization for diabetes-related complications among 
diabetics and on hospitalization for angina among respondents at risk for angina 
(i.e., coronary heart disease, high blood pressure, diabetes, and past myocardial 
infarction).
31 The 15 types of preventable admissions we can identify in the MCBS claims are: diabetes short-term com-
plications; perforated appendix; diabetes long-term complications; chronic obstructive pulmonary disease (COPD) 
or asthma in older adults; hypertension; heart failure; dehydration; bacterial pneumonia; urinary tract infection; 
angina without procedure; uncontrolled diabetes; asthma in younger adults; and lower-extremity amputation among 
patients with diabetes. We follow the definitions of Prevention Quality Indicators by the Agency for Healthcare 
Research and Quality in constructing these indicators. 
Table 6—Effects of Eligibility Expansions on Mortality (t + 1) for Duals
Coefficient from LPM of mortality in year t + 1
  (1) (2) (3) (4) (5)
SimElig (t − 1) −0.0001 −0.0014 −0.0010 −0.0024 −0.0019
(0.0023) (0.0027) (0.0029) (0.0026) (0.0026)
SimElig (t − 2) −0.0019 −0.0012
(0.0012) (0.0012)
SimElig (t − 3) 0.0017
(0.0009)
 
_
 y = 0.072  _ y = 0.072  _ y = 0.072  _ y = 0.072  _ y = 0.072
(0.258) (0.258) (0.258) (0.258) (0.258)
Observations 4,397 3,877 3,877 3,346 3,346
Notes: All models control for age and age squared, highest level of educational attainment, 
sex, race or ethnicity, veteran status, marital status, urban residence, household income and 
its square, enrollment in FFS Medicare, smoking participation, BMI, the number of chronic 
conditions, the percent of state Medicaid enrollees in comprehensive MCO plans, and the 
state unemployment rate. All models also include year and state fixed effects and a full set 
of state-specific linear time trends. Column 1 uses the relevant sample for 2001–2009 (years 
for which available data allow consideration of a one-year lag of SimElig); columns 2–3 use 
the relevant sample for 2002–2009 (years for which available data allow consideration of a 
 two-year lag); columns 4–5 use the relevant sample for 2003–2009 (years for which avail-
able data allow consideration of a three-year lag). Robust standard errors clustered by state are 
reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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C. Longer Term Effects on Spending and Health
We next consider whether the spending effects we observe are short-term transi-
tory effects or persistent effects. In Table 7, we report the results of two-part mod-
els of spending in which we add lagged values of the key explanatory variable. In 
the first row of the top panel, we report the main results shown earlier, for ease of 
comparison.32 The results from allowing Medicaid eligibility to have longer lagged 
effects are reported in the remainder of the table. Models with two lags show that 
Medicaid expansions continue to reduce inpatient and outpatient hospital health-
care in the second year following the expansion. Models with three lags show that 
even in the third year after the expansion, there is still some reduction in dually 
enrolled seniors’ healthcare spending, albeit to a lesser extent. Overall, the results 
32 We also ran these models with the somewhat smaller samples that result when we allow Medicaid expansions 
to enter with additional lags, so as to correspond with the samples used in the bottom two panels of the table. We 
found similar effect sizes when we drop 2001 data and 2001–2002 data from the samples. 
Table 7—Short- and Long-Term Effects of Eligibility Expansions on Spending and Self-Reported 
Health Status for Duals
All payer healthcare spending measures, 2009$ General health measures
 
Total 
payments
Inpatient 
events
Medical 
provider 
events
Outpatient 
hospital 
events
Prescribed 
medicine 
events
General 
health is 
fair or 
poor
Health 
limits 
social 
activities
Health 
is worse 
than one 
year ago
  (1) (2) (3) (4) (5) (6) (7) (8)
SimElig (t − 1), −476.602 −229.681 −94.239 −52.098 −2.170 −0.0005 −0.0020 0.0010
 original sample (82.82) (57.94) (35.57) (12.93) (9.80) (0.0014) (0.0023) (0.0024)
Models with two lags
SimElig (t − 1) −384.185 −195.536 −71.848 −32.191 3.756 0.0019 0.0003 0.0031
(81.60) (63.77) (42.11) (14.82) (6.81) (0.0018) (0.0017) (0.0025)
SimElig (t − 2) −160.388 −69.757 −41.897 −52.863 −7.981 0.0008 −0.0023 0.0002
(106.71) (42.10) (35.85) (13.74) (13.58) (0.0028) (0.0023) (0.0025)
Models with three lags
SimElig (t − 1) −449.889 −261.482 −66.981 −31.233 2.435 0.0028 −0.00008 0.0013
(96.98) (90.28) (55.00) (24.04) (9.85) (0.0016) (0.0016) (0.0026)
SimElig (t − 2) −115.342 −97.255 −33.877 −20.869 −9.858 0.0042 0.0004 −0.0004
(115.65) (51.04) (37.71) (18.89) (13.65) (0.0028) (0.0026) (0.0029)
SimElig (t − 3) −183.020 −126.356 −40.555 −35.490 15.363 −0.0028 −0.0018 0.0013
(95.36) (78.93) (22.58) (23.88) (13.47) (0.0019) (0.0021) (0.0020)
Notes: Sample sizes range from 7,170 to 7,679 for the original sample; 6,444 to 6,847 for the two-year lag sample; 
and 5,561 to 6,014 for the three-year lag sample. All models control for age and age squared, highest level of edu-
cational attainment, sex, race or ethnicity, veteran status, marital status, urban residence, household income and its 
square, enrollment in FFS Medicare, smoking participation, BMI, the number of chronic conditions (not included 
in columns 6–8), the percent of state Medicaid enrollees in comprehensive MCO plans, and the state unemployment 
rate. All models also include year and state fixed effects and a full set of state-specific linear time trends. Controls 
for the hospital wage index and three physician practice costs indices are added to models of all service spending; 
the hospital wage index is added to models of inpatient and outpatient hospital spending and physician practice cost 
indices are added to models of medical provider spending. Row 1 uses the relevant sample for 2001–2009 (years 
for which available data allow consideration of a one-year lag of SimElig); rows 2 and 4 for 2002–2009 (allowing 
consideration of a two-year lag); rows 3 and 5 for 2003–2009 (allowing consideration of a three-year lag).
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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from Table 7 suggest that Medicaid expansions have more pronounced short-run 
effect on duals’ spending, but that reductions can persist for several years.
We next examine the long-term effects of Medicaid expansions on health. 
Although results presented earlier showed no immediate adverse health effects, we 
are interested in whether expansions have health effects that manifest over time. 
The first row of Table 7, columns 6–8, reproduces our earlier results from models of 
self-reported health, for ease of comparison. The panels below report models with 
additional lags of simulated eligibility; the results provide no evidence that increases 
in Medicaid expansion have stronger negative health effects over time.33 Finally, 
we look at whether there are mortality effects when we allow for longer lags of the 
Medicaid expansions variable. These models are reported in columns 3 and 5 of 
Table 6. In column 5, we find that increases in simulated eligibility have a positive 
and marginally significant effect on duals’ mortality within three years. Specifically, 
a 1 percentage point increase in simulated eligibility increases the probability of 
dying in 3 years by 0.17 percentage points, or 2.4 percent. Though statistically sig-
nificant, this is a small effect; in addition, it is not robust to the inclusion of addi-
tional lags of simulated eligibility (e.g., over 4 or 5 periods; results available upon 
request).
D. Sample Selection, Care Coordination, or Preexisting Trends?
Thus far we have documented reductions in healthcare spending and utiliza-
tion among dual eligible enrollees that are consistent with negative spillovers 
from Medicaid to Medicare. We next explore potential threats to our identification 
 strategy.34 First, we examine whether the findings could be explained by sample 
selection. We consider two types of selection into the sample of dual eligibles. One 
type of selection could occur through mortality. For example, if increased mortality 
among the dual population is tied to Medicaid expansions, reductions in healthcare 
spending could reflect an improvement in the average health of those duals who 
remain in our sample, as opposed to reduced access to care. We test for this type of 
selection into the dual eligible sample in Table 8, column 1. The dependent variable 
is equal to one if the respondent died in year t, thus making the individual ineligible 
for inclusion in analysis of our main results on healthcare spending, utilization, and 
health; note that this model differs from the Table 6 models, where the dependent 
variable is equal to one if the respondent died in year t + 1. We find that the coef-
ficient on the Medicaid expansion variable is very small and insignificant, and thus 
we rule out this type of selection.
33 When we estimate our original model with restricted samples used for the models with additional lags, there 
is one health measure (general health is fair or poor) for which restricting the sample to 2003 to 2009 results in a 
positive and significant effect of Medicaid expansions (result not shown), but the bulk of the evidence suggests no 
self-reported health effects. 
34 In addition to the explanations we examine here, another possibility is that eligibility changes occur at the 
same time as other policy changes related to Medicaid programs. We look at the relationship between changes over 
time in simulated eligibility and changes in Medicaid physician payment and managed care enrollment during years 
for which these data are available, and find no evidence that changes in eligibility are correlated with changes in 
these policy variables (results available upon request). 
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Another type of selection that may explain our results is the so-called “welcome 
mat effect,” whereby persons who were previously eligible for Medicaid enroll 
when a state expands Medicaid coverage to another population. The welcome mat 
effect could explain our results if the duals who newly enroll in Medicaid are health-
ier, on average; as a result, the changing composition of the dual population drives 
down average spending. We also test for this type of selection in Table 8. In col-
umns 2 through 5, we estimate models of Medicaid participation among a sample of 
MCBS respondents who are likely to be eligible for full Medicaid coverage—those 
whose household income is below 100 percent of the federal poverty level defined 
for their household type, age, and year in the sample. We follow Pezzin and Kasper 
(2002) and Ungaro and Federman (2009) in the construction of the sample and the 
inclusion of specific controls. We first examine the effect of the simulated Medicaid 
eligibility measure; in column 2, its estimated coefficient is positive but statisti-
cally insignificant (p = 0.15). In the remaining columns, we test whether Medicaid 
expansions have welcome mat effects for those in good health. We interact the sim-
ulated eligibility measure with different indicators for good health: reporting no 
chronic conditions, reporting no difficulties with activities of daily living (ADLs), 
and reporting no difficulties with instrumental activities of daily living (IADLs). In 
each case, the interaction term is insignificant, suggesting that healthier low-income 
seniors are no more likely to take-up Medicaid during state Medicaid expansions to 
the working-age population.
We next look at whether the reductions in healthcare utilization among duals 
reflect state efforts to coordinate duals’ care coinciding with Medicaid  expansions. 
Table 8—Tests for Selection: Effects of Eligibility Expansions on Mortality (year t) and Medicaid 
Receipt of Senior Medicare Beneficiaries
Mortality 
in year t Medicaid receipt in year t
Sample 
of dual 
eligibles
Sample of individuals 
in households with income 
<100 percent FPL
(1) (2) (3) (4) (5)
SimElig (t − 1) −0.0003
(0.0003)
0.0019
(0.0013)
0.0017
(0.0013)
0.0029
(0.0012)
0.0020
(0.0016)
SimElig (t − 1) × no chronic conditions — 0.0013(0.0032)
— —
SimElig (t − 1) × no ADLs — — −0.0018
(0.0015)
—
SimElig (t − 1) × no IADLs — — — −0.0002
(0.0014)
Notes: The mean of the mortality dependent variable is 0.0057; there are 7,684 observations in the mortality model. 
The mean of the Medicaid receipt dependent variable is 0.48; there are 9,190 observations in the Medicaid receipt 
models. All models include controls for age and age squared, highest level of educational attainment, sex, race or 
ethnicity, veteran status, marital status, urban residence, household income and its square, smoking participation, 
BMI, number of chronic conditions, the percent of state Medicaid enrollees in comprehensive MCO plans, and the 
state unemployment rate; the Medicaid receipt models also include an indicator for incontinence, controls for the 
numbers of limitations in activities of daily living and independent activities of daily living. All models also include 
year and state fixed effects as well as state-specific linear time trends. Robust standard errors clustered by state are 
reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
VoL. 9 No. 3 433McINERNEY ET AL.: SPILLOVERS FROM MEDICAID TO MEDICARE
Data reported by Gold, Jacobson, and Garfield (2012) show a nationwide increase 
in the share of duals in Medicare Advantage (MA) plans, including Dual Special 
Needs Plans or D-SNPs over the 2000s. Specifically, the share of duals in MA plans 
increased from 10 percent in 2000 to nearly 20 percent in 2008. If MA plans lower 
spending, and their enrollment is increasing in the same states and years in which 
working-aged eligibility expansions occur, our results may reflect this shift and not 
spillover effects. Annual state-level estimates of Medicare Advantage enrollment 
among duals are not available so we cannot control for this change directly, but we 
explore this issue indirectly. We exclude duals residing in the states where more than 
25 percent of the duals are enrolled in Medicare Advantage in 2010, as reported by 
Gold, Jacobson, and Garfield (2012). These states are Arizona, Hawaii, Minnesota, 
New Mexico, Oregon, Tennessee, and Vermont. The results are shown in Table 9, 
column 1. Outside of these states, we continue to see that increases in Medicaid eli-
gibility for working-age adults reduces duals’ healthcare spending. Column 2 shows 
that results are similar when we also exclude duals in California (where 20.1 percent 
of duals are enrolled in MA). Thus, these results suggest that rising enrollment in MA 
plans is not responsible for the decline in average healthcare spending among duals.
Finally, we examine whether the healthcare spending declines we observe could 
be the result of a preexisting trend, even though all of our models already include 
controls for state-specific time trends. In Table 10, we conduct a falsification test in 
which we replace the simulated eligibility measure by a one-period lead and then a 
two-period lead. Since we have the simulated eligibility measure through 2014, we 
are able to include the leads without reducing the sample size. The coefficients on the 
one-period lead variable are usually negative, but they are a small fraction of their size 
in the main results table (Table 1) and they are never statistically significant. The coef-
ficients on the two-period lead variable are also not statistically significant. Overall, 
the falsification test results rule out a preexisting trend of declining healthcare spend-
ing for duals in states that expanded Medicaid eligibility to  working-age adults.
V. Discussion
In this study, we find new evidence that public insurance expansions have nega-
tive spillover effects on spending and utilization among the already insured popu-
lation. Specifically, dual eligibles experience reductions in healthcare spending and 
utilization when states expand Medicaid eligibility to working-age adults. We show 
that this occurs through reductions in both inpatient hospital care and outpatient care 
(both medical provider events and outpatient hospital care). The leading explana-
tion for our results is that they stem from physician responses to changes in fixed 
 practice components in response to an increase in the share of patients covered by 
more restrictive insurance.35
Our work has important policy implications related to Medicaid expansions. First, 
we see no evidence that the majority of Medicare beneficiaries are made worse off in 
35 Note that the presence of the expected spillover effects and the mechanisms underlying them may differ in 
other contexts, such as dental care, where mid-level practitioners play a central role in providing care (Buchmueller, 
Miller, and Vujicic 2014). 
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terms of their access to care. Second, even though dual eligibles experience reductions 
in care, we see little evidence that these spending reductions are negative from a wel-
fare perspective. Duals are no more likely to report poor/fair health when Medicaid 
expansions occur, there is no change in their receipt of preventive care, and there is 
little evidence of increases in their mortality rates following Medicaid expansions. 
Duals in FFS Medicare are less likely to be hospitalized for conditions like COPD, 
asthma, diabetes, and angina. In light of our results for self-reported health, preven-
tive care, and mortality, we interpret the declines in preventable hospitalizations as 
improvements in ambulatory care (as Joynt et al. 2013 interpret their findings), and 
not as delays in hospital admission resulting from possible congestion.
Using microdata from the MCBS yields some results that are similar to Glied 
(2014), and others that differ. The spending reductions we estimate for the entire 
Table 9—Effects of Eligibility Expansions for Duals, Excluding States with 
Large Share of Duals in Medicare Advantage
Marginal effect of SimElig (t − 1)
Including California Excluding California
(1) (2)
Panel A. All payer spending, 2009$
Total payments, all sources −517.325 −558.006
(120.26) (202.54)
All payments for inpatient events −251.649 −263.839
(78.30) (115.82)
All payments for medical provider −104.243 −129.861
 events (37.01) (55.35)
All payments for outpatient hospital −51.508 −51.190
 events (19.20) (19.97)
All payments for prescribed medicine −9.455 6.848
 events (10.96) (17.17)
Panel B. Healthcare utilization Poisson coefficient on SimElig (t − 1)
Number of inpatient events −0.062 −0.069
(0.012) (0.017)
Number of medical providers −0.028 −0.025
(0.008) (0.012)
Number of outpatient hospital events −0.013 −0.026
(0.013) (0.014)
Number of prescribed medicine events −0.003 −0.004
(0.003) (0.005)
Notes: The sample size in column 1 ranges from 6,703 to 7,156. Sample sizes for regres-
sions in column 2 ranges from 5,907 to 6,145. Sample excludes duals residing in states where 
more than 25 percent of duals are enrolled in MA plans (i.e., Arizona, Hawaii, Minnesota, 
New Mexico, Oregon, Tennessee, and Vermont. All models include controls for age and age 
squared, highest level of educational attainment, sex, race or ethnicity, veteran status, marital 
status, urban residence, household income and its square, smoking participation, BMI, number 
of chronic conditions, the percent of state Medicaid enrollees in comprehensive MCO plans, 
and the state unemployment rate. All models also include year and state fixed effects and a full 
set of state-specific linear time trends. Controls for the hospital wage index and three physi-
cian practice costs indices are added to models of all service spending; the hospital wage index 
is added to models of inpatient and outpatient hospital spending and physician practice cost 
indices are added to models of medical provider spending. Robust standard errors clustered by 
state are reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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Medicare population are similar in magnitude to Glied (2014), who found that states 
enacting substantial expansions in parental CHIP eligibility (i.e., a 5 percentage 
point increase in simulated eligibility or more) experience declines in aggregate per 
capita Medicare Part B spending of 3.2 percent. Similarly, our estimates suggest that 
a 5 percentage point increase in Medicaid eligibility leads to a $47 or 5.7 percent 
reduction in Medicare outpatient spending (and no statistically significant differ-
ence in Medicare spending to medical providers). In contrast to that prior study, 
we examine and find heterogeneous effects by type of beneficiary. Specifically, the 
reductions in healthcare spending we observe are concentrated among dual eligi-
bles, for whom these reductions are sizeable. A 5 percentage point increase in the 
share of working-age adults eligible for Medicaid in the state reduces the average 
duals’ Medicare outpatient spending by 18.3 percent (or $212) and payments for 
medical provider events by 14.6 percent (or $399).
We estimate that the Medicaid expansions we study are comparable in magni-
tude to expansions under the ACA. Among states with a large expansion over our 
study period, the mean increase in simulated eligibility is 12.6 percentage points. 
To illustrate how this compares to ACA expansions, we use our simulated eligibility 
measure for 2013 to 2014 and calculate the average change in simulated eligibility 
in ten states that implemented the ACA Medicaid expansion in 2014, but did not 
previously have a large expansion to non-elderly adults.36 Among these states, the 
average change in simulated eligibility is 11.5 percentage points and state-specific 
increases range from 5 to 15 percentage points.
36 This group of states includes Arkansas, Colorado, Illinois, Kentucky, Michigan, Nevada, North Dakota, Ohio, 
Rhode Island, and West Virginia. 
Table 10 —Falsification Test: Effect of Lead Simulated Eligibility on Healthcare Spending among 
Duals
All payer healthcare spending measures, 2009$
Total 
payments
Inpatient 
events
Medical 
provider events
Outpatient 
hospital events
Prescribed 
medicine events
(1) (2) (3) (4) (5)
SimElig (t + 1) −62.163 −49.211 −3.215 33.358 −19.149
(145.44) (64.25) (37.82) (21.41) (20.88)
SimElig (t + 2) 61.237 101.071 −4.402 19.499 −8.338
(113.02) (72.29) (40.70) (44.45) (15.70)
Observations 7,170 7,679 7,461 7,679 7,507
Notes: All models control for age and age squared, highest level of educational attainment, sex, race or ethnicity, 
veteran status, marital status, urban residence, household income and its square, Medicaid coverage, enrollment in 
FFS Medicare, smoking participation, BMI, the number of chronic conditions, the percent of state Medicaid enroll-
ees in comprehensive MCO plans, and the state unemployment rate. All models also include year and state fixed 
effects and a full set of state-specific linear time trends. Controls for the hospital wage index and three physician 
practice costs indices are added to models of all service spending; the hospital wage index is added to models of 
inpatient and outpatient hospital spending and physician practice cost indices are added to models of medical pro-
vider spending. Robust standard errors clustered by state are reported in parentheses.
Source: Authors’ calculations based on Medicare Current Beneficiary Survey data
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The ACA also provides a context for comparing the size of the spillover reduc-
tions in Medicare spending to the size of the increases in Medicaid spending result-
ing from Medicaid expansions. To do this, we calculate the change in simulated 
eligibility associated with the ACA and draw on estimates of the ACA’s impact on 
Medicaid coverage and Medicaid’s impact on spending. Our back-of-the-envelope 
calculation suggests that Medicaid eligibility expansions increase healthcare spend-
ing overall, but the negative spillovers we estimate offset a portion of the increased 
healthcare spending driven by state-level Medicaid expansions.37 This finding also 
suggests that supply-side capacity is not entirely fixed; healthcare suppliers have 
some capacity to expand their services.
Although our study has a number of strengths, it also has some limitations. 
Relative to the prior literature on this topic, the strengths include its national focus, 
our use of microdata on healthcare spending, use, and health to analyze heteroge-
neous effects by type of Medicare beneficiary and state Medicaid payment gen-
erosity. Further, we look very closely at whether changes in the composition of 
the dual population are driving the results and at alternate explanations like care 
coordination and preexisting trends. An important weakness is the limited detail on 
health. We observe mortality, but there are small numbers of deaths in the samples, 
and we have no detail on specific causes of death. We also rely on somewhat crude 
measures of self-reported health, as opposed to more detailed instruments like the 
SF-20 or SF-12. Nonetheless, taken as a whole, our results indicate negative spill-
overs in terms of spending and utilization, but no deleterious effects on health. This 
suggests that the spillovers from Medicaid expansions may reduce unnecessary or 
inefficient care and the observed reductions in spending are unlikely to have nega-
tive welfare effects.
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